Leukemia Lymphoblastic Acute Philadelphia-positive
📧 Sign up to get email alerts when something new happens for Leukemia Lymphoblastic Acute Philadelphia-positive.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial of dasatinib for Philadelphia-positive acute lymphoblastic leukemia has completed.